{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:40:21Z","timestamp":1789702821717,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":4201,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1046\/j.1469-0691.2003.00725.x","type":"journal-article","created":{"date-parts":[[2003,7,7]],"date-time":"2003-07-07T15:10:55Z","timestamp":1057590655000},"page":"512-517","source":"Crossref","is-referenced-by-count":26,"title":["Mechanism of quinolone resistance in anaerobic bacteria"],"prefix":"10.1016","volume":"9","author":[{"given":"H.","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Edlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1046\/j.1469-0691.2003.00725.x_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2165\/00003495-199958002-00012","article-title":"Quinolone activity against anaerobes","volume":"58","author":"Appelbaum","year":"1999","journal-title":"Drugs"},{"issue":"suppl 1","key":"10.1046\/j.1469-0691.2003.00725.x_bib2","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/clinids\/23.Supplement_1.S25","article-title":"Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety","volume":"23","author":"Goldstein","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib3","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/AAC.46.3.866-870.2002","article-title":"In vitro activities of the des-fluoro (6) quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections","volume":"46","author":"Goldstein","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib4","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1128\/AAC.44.12.3351-3356.2000","article-title":"Antibacterial spectrum of a novel des-fluoro (6) quinolone, BMS-284756","volume":"44","author":"Fung-Tomc","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/40.5.639","article-title":"Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin","volume":"40","author":"Bauernfeind","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jac\/48.1.127","article-title":"Susceptibility of the Bacteroides fragilis group to newer quinolones and other standard anti-anaerobic agents","volume":"48","author":"Horn","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/AAC.44.4.1102-1107.2000","article-title":"In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates","volume":"44","author":"Milatovic","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib8","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1128\/AAC.43.10.2417","article-title":"Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996","volume":"43","author":"Snydman","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib9","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.45.6.1896-1899.2001","article-title":"Comparative in vitro activities of gemifloxacin, other quinolones, and nonquinolone antimicrobials against obligately anaerobic bacteria","volume":"45","author":"Kleinkauf","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 2","key":"10.1046\/j.1469-0691.2003.00725.x_bib10","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/314056","article-title":"Mechanisms of action and resistance of older and newer fluoroquinolones","volume":"31","author":"Hooper","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3201\/eid0702.010239","article-title":"Emerging mechanisms of fluoroquinolone resistance","volume":"7","author":"Hooper","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib12","first-page":"410","article-title":"Refining the fluoroquinolones","volume":"65","author":"Drlica","year":"1999","journal-title":"ASM News"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/jac\/42.6.683","article-title":"Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg?","volume":"42","author":"Martinez","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/276090a0","article-title":"Plasmid-determined tetracycline resistance involves new transport systems for tetracycline","volume":"276","author":"Levy","year":"1978","journal-title":"Nature"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib15","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/AAC.44.9.2233-2241.2000","article-title":"Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria","volume":"44","author":"Poole","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/scdb.2000.0247","article-title":"Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria","volume":"12","author":"Nikaido","year":"2001","journal-title":"Semin Cell Dev Biol"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib17","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1128\/AAC.36.8.1601","article-title":"Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus","volume":"36","author":"McCaffrey","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib18","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.33.8.1318","article-title":"Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction","volume":"33","author":"Cohen","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1006\/bbrc.2000.3159","article-title":"Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae","volume":"274","author":"Chevalier","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib20","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1128\/AAC.45.4.1238-1243.2001","article-title":"Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species","volume":"45","author":"Aldridge","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib21","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1086\/341934","article-title":"National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000","volume":"35","author":"Snydman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib22","doi-asserted-by":"crossref","DOI":"10.1046\/j.1469-0691.2003.00674.x","article-title":"Antimicrobial susceptibility of Bacteroides fragilis isolates in Europe","author":"Hedberg","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib23","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/AAC.44.6.1710-1712.2000","article-title":"Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of bacteroides fragilis group: effect of the medium on test results","volume":"44","author":"Snydman","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib24","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/AAC.46.10.3276-3279.2002","article-title":"In vitro activities of newer quinolones against bacteroides group organisms","volume":"46","author":"Snydman","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib25","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/AAC.45.7.1977-1981.2001","article-title":"gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains","volume":"45","author":"Oh","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0924-8579(01)00486-1","article-title":"Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates","volume":"19","author":"Speciale","year":"2002","journal-title":"Int J antomicrob Agents"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s100960050465","article-title":"Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria","volume":"19","author":"Ackermann","year":"2000","journal-title":"Eur J Clin Micorbiol Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0732-8893(01)00247-4","article-title":"Activity of BMS-284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp","volume":"40","author":"Rhomberg","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jac\/47.2.195","article-title":"In vitro activity of new quinolones against Clostridium difficile","volume":"47","author":"Alonso","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1046\/j.1469-0691.2003.00725.x_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/45.suppl_3.1","article-title":"Comparative in vitro activity of gemifloxacin","volume":"45","author":"King","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib31","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1128\/AAC.46.11.3418-3421.2002","article-title":"gyrA and gyrB mutations are implicated in cross-resistance to ciprofloxacin and moxifloxacin in Clostridium difficile","volume":"46","author":"Dridi","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib32","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1128\/AAC.45.8.2348-2353.2001","article-title":"Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA","volume":"45","author":"Ackermann","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib33","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1128\/AAC.43.10.2423","article-title":"Molecular cloning of the gyrA and gyrB genes of Bacteroides fragilis encoding DNA gyrase","volume":"43","author":"Onodera","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib34","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/AAC.44.7.1842-1845.2000","article-title":"Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin","volume":"44","author":"Bachoual","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib35","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1128\/AAC.44.9.2361-2366.2000","article-title":"Accumulation of norfloxacin by Bacteroides fragilis","volume":"44","author":"Ricci","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib36","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1128\/AAC.42.8.2119","article-title":"Active efflux of norfloxacin by Bacteroides fragilis","volume":"42","author":"Miyamae","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib37","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1128\/AAC.45.12.3341-3346.2001","article-title":"A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron","volume":"45","author":"Miyamae","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib38","first-page":"277","article-title":"Efflux-mediated quinolone resistance in Bacteroides fragilis group strains","volume":"8","author":"Oh","year":"2003","journal-title":"Anaerobe"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib39","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1128\/AAC.46.10.3257-3260.2002","article-title":"A resistance-modulation-cell division family xenobiotic efflux pump in an obligate anaerobe, Porphyromonas gingivalis","volume":"46","author":"Ikeda","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib40","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jac\/18.5.575","article-title":"Elimination of plasmids by enoxacin and ofloxacin at near inhibitory concentrations","volume":"18","author":"Weisser","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(97)07322-4","article-title":"Quinolone resistance from a transferable plasmid","volume":"351","author":"Martinez-Martinez","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib42","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1073\/pnas.082092899","article-title":"Mechanism of plasmid-mediated quinolone resistance","volume":"99","author":"Tran","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/338571","article-title":"Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window","volume":"185","author":"Zhao","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib44","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1128\/AAC.45.7.2136-2140.2001","article-title":"Fluoroquinolone resistance in anaerobic bacteria following exposure to levofloxacin, trovafloxacin, and sparfloxacin in an in vitro pharmacodynamic model","volume":"45","author":"Ross","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1128\/AAC.46.1.203-210.2002","article-title":"Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model","volume":"46","author":"Peterson","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"10.1046\/j.1469-0691.2003.00725.x_bib46","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1086\/314059","article-title":"Clinical pharmacology of the fluoroquinolones: stidies in human dynamic\/kinetic models","volume":"31","author":"Schentag","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib47","first-page":"368","article-title":"The effect of DU-6859a, a new potent fluoroquinolone, on fecal microflora in human volunteers","volume":"48","author":"Inagaki","year":"1995","journal-title":"Jpn J Antibiot"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib48","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s150100070018","article-title":"Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone","volume":"28","author":"Oh","year":"2000","journal-title":"Infection"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1469-0691.2002.00414.x","article-title":"Ecological impact of the des-F (6)-quinolone, BMS-284756, on the normal intestinal microflora","volume":"8","author":"Nord","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1046\/j.1469-0691.2003.00725.x_bib50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/00365540050164272","article-title":"Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora","volume":"32","author":"Edlund","year":"2000","journal-title":"Scand J Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14640015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14640015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T17:16:49Z","timestamp":1585070209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14640015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S1198743X14640015"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00725.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}